REDWOOD CITY, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Threshold Pharmaceuticals, Inc. , today announced that it will present at the following investor conferences in November 2006:
Rodman & Renshaw 8th Annual Healthcare Conference
Threshold's CEO, Barry Selick, Ph.D., will present at 4:35 p.m. Eastern Time on Monday, November 6 at the New York Palace Hotel in New York.
CIBC World Markets 17th Annual Healthcare Conference
Threshold's interim CMO, Michael Brawer, M.D., will present at 3:00 p.m. Eastern Time on Wednesday, November 8 at the Waldorf-Astoria in New York.
Cowen & Company 7th Annual Global Healthcare Conference
Threshold's CEO, Barry Selick, Ph.D., will present at 4:10 p.m. on Wednesday, November 8 at the Landmark Hotel in London.
The live audio broadcasts and the subsequent archived recordings of these conferences can be accessed at the "Investor" section of the Company's website, http://www.thresholdpharm.com , under "Webcasts."
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. By selectively targeting abnormally-proliferating tumor cells, the Company's drug candidates are designed to be potentially more effective and less toxic to healthy tissues than conventional treatments. For additional information, please visit our website (www.thresholdpharm.com ).
Contact: Denise T. Powell Sr. Director, Corporate Communications Threshold Pharmaceuticals, Inc. 650-474-8206 dpowell@thresholdpharm.com
Threshold Pharmaceuticals, Inc.CONTACT: Denise T. Powell, Senior Director of Corporate Communications, ofThreshold Pharmaceuticals, Inc., +1-650-474-8206, ordpowell@thresholdpharm.com
Web site: http://www.thresholdpharm.com/
